AMLX
Price
$10.20
Change
+$0.25 (+2.51%)
Updated
Sep 5 closing price
Capitalization
887.22M
61 days until earnings call
LRMR
Price
$3.94
Change
+$0.06 (+1.55%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
337.23M
73 days until earnings call
Interact to see
Advertisement

AMLX vs LRMR

Header iconAMLX vs LRMR Comparison
Open Charts AMLX vs LRMRBanner chart's image
Amylyx Pharmaceuticals
Price$10.20
Change+$0.25 (+2.51%)
Volume$1.75M
Capitalization887.22M
Larimar Therapeutics
Price$3.94
Change+$0.06 (+1.55%)
Volume$12.57K
Capitalization337.23M
AMLX vs LRMR Comparison Chart in %
Loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. LRMR commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Buy and LRMR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (AMLX: $10.20 vs. LRMR: $3.94)
Brand notoriety: AMLX and LRMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 125% vs. LRMR: 114%
Market capitalization -- AMLX: $887.22M vs. LRMR: $337.23M
AMLX [@Biotechnology] is valued at $887.22M. LRMR’s [@Biotechnology] market capitalization is $337.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileLRMR’s FA Score has 1 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • LRMR’s FA Score: 1 green, 4 red.
According to our system of comparison, both AMLX and LRMR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 3 TA indicator(s) are bullish while LRMR’s TA Score has 5 bullish TA indicator(s).

  • AMLX’s TA Score: 3 bullish, 4 bearish.
  • LRMR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, LRMR is a better buy in the short-term than AMLX.

Price Growth

AMLX (@Biotechnology) experienced а +8.74% price change this week, while LRMR (@Biotechnology) price change was +8.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

AMLX is expected to report earnings on Nov 06, 2025.

LRMR is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($887M) has a higher market cap than LRMR($337M). AMLX YTD gains are higher at: 169.841 vs. LRMR (1.809). LRMR has higher annual earnings (EBITDA): -108.21M vs. AMLX (-196.3M). AMLX has more cash in the bank: 181M vs. LRMR (139M). LRMR has less debt than AMLX: LRMR (4.61M) vs AMLX (5.96M). LRMR has higher revenues than AMLX: LRMR (0) vs AMLX (-249K).
AMLXLRMRAMLX / LRMR
Capitalization887M337M263%
EBITDA-196.3M-108.21M181%
Gain YTD169.8411.8099,390%
P/E Ratio2.69N/A-
Revenue-249K0-
Total Cash181M139M130%
Total Debt5.96M4.61M129%
FUNDAMENTALS RATINGS
LRMR: Fundamental Ratings
LRMR
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXLRMR
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 8 days ago
82%
Bearish Trend 19 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AWSRX17.30N/A
N/A
Invesco Global Core Equity R
RYDAX108.01N/A
N/A
Rydex Dow Jones Industrial Average® A
ACLAX16.69N/A
N/A
American Century Mid Cap Value A
LMOPX40.46N/A
N/A
Patient Opportunity C
TDFCX8.42N/A
N/A
Transamerica Sustainable Equity Inc C

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been closely correlated with XOMAO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if AMLX jumps, then XOMAO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
+2.51%
XOMAO - AMLX
68%
Closely correlated
-0.03%
XOMAP - AMLX
51%
Loosely correlated
+0.41%
RGNX - AMLX
46%
Loosely correlated
+3.08%
LRMR - AMLX
44%
Loosely correlated
+1.81%
OCUL - AMLX
44%
Loosely correlated
+7.09%
More